Abstracts tagged "Nonsteroidal antiinflammatory drugs (NSAIDs) and osteoarthritis"

Abstract Number: 2350 • ACR/ARHP Annual Meeting 2018
Examining Ethnic Differences in Osteoarthritis (OA) Patients’ Knowledge and Attitudes Regarding Prescription Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Hana Masood¹, Michael J. Hannon², C. Kent Kwoh¹, Jazmin Dagnino³ and Ernest Vina⁴, ¹Medicine, Division of Rheumatology, University of Arizona School of Medicine, University of Arizona Arthritis Center, Tucson, AZ, ²Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, ³University of Arizona Arthritis Center, Tucson, AZ, ⁴University of Arizona School of Medicine, University of Arizona Arthritis Center, Tucson, AZ
Background/Purpose: NSAIDs are commonly prescribed for the treatment of OA. While there are documented differences between Hispanics and non-Hispanic whites (NHWs) in their treatment preferences…
Abstract Number: 2232 • ACR/ARHP Annual Meeting 2014
Cost-Effectiveness of Glucosamine, Chondroitin Sulfate, Their Combination, Celecoxib,Non-Selective Non-Steroidal Anti-Inflammatory Drugs, and Placebo in Treating Knee Osteoarthritis
Vishvas Garg¹, Dennis Raisch², Ning Yan Gu³, Matthew E Borrego³ and Daniel O. Clegg⁴, ¹College of Pharmacy, University of New Mexico (at the time of research), Grayslake, IL, ²College of Pharmacy, University of New Mexico, Albuquerque, NM, ³University of New Mexico, Albuquerque, NM, ⁴Rheumatology, George Wahlen VA Medical Center/University of Utah, Salt Lake City, UT
Background/Purpose: Knee osteoarthritis (KOA) affects 13.8% of the US population aged ≥26, causing significant burden-of-illness. We compared the cost-effectiveness of conventional medicines such as non-steroidal…
Abstract Number: 1130 • ACR/ARHP Annual Meeting 2012
The Effect of Age On the Number of Osteoarthritis Flares with Continuous Versus Intermittent Celecoxib Treatment
George H. Sands, Pritha Bhadra and Margaret Noyes Essex, Pfizer, Inc, New York, NY
Background/Purpose: Continuous nonsteroidal anti-inflammatory drug (NSAID) treatment is significantly more efficacious than intermittent dosing1during 22-weeks in preventing flares in patients with osteoarthritis (OA) of the…
Abstract Number: 261 • ACR/ARHP Annual Meeting 2012
Effect of Advancing Age On the Gastrointestinal Safety of Celecoxib Versus Nonselective Nonsteroidal Anti-Inflammatory Drugs: A Post Hoc Analysis of GI-Reasons
Lee S. Simon¹, Byron Cryer², Gurkirpal Singh³, Chunming Li⁴ and Margaret Noyes Essex⁵, ¹SDG LLC Consulting, West Newton, MA, ²University of Texas Southwestern Medical Center, Dallas, TX, ³Gastroenterology/Hepatology, Stanford University School of Medicine, Palo Alto, CA, ⁴Pfizer Inc, New York, NY, ⁵Pfizer, Inc, New York, NY
Background/Purpose: Celecoxib use was associated with a lower risk of clinically relevant upper and lower GI events than nonselective (ns)NSAIDs in patients (≥ 55 years)…